摘要
新辅助治疗可使原发肿瘤或转移病灶缩小,降低肿瘤分期,已被认为是进展期结直肠癌(ACRC)的主要治疗方式。但由于肠道为空腔脏器,原发病灶准确测量困难,新辅助治疗后的疗效评估更加困难。因此,就结直肠癌而言,目前缺乏统一的、有针对性的、效果明显的评价系统和标准。本文就ACRC新辅助治疗目前疗效评价方法做一综述。
The primary or metastatic tumor,even the tumor stage may be reduced after neoadjuvant therapy,and it has been considered as the main treatment for advanced colorectal cancer( ACRC). However,the accurate measurement of the primary lesion in hollow organ,such as the intestine,is difficult,so as the evaluation of the therapeutic effect after neoadjuvant therapy. Therefore,there is no unified,targeted,and effective evaluation systems and standards for colorectal cancer,and this article reviews the current efficacy evaluation methods of ACRC neoadjuvant therapy.
作者
詹红丽
王蓉
王雯
Zhan Hongli;Wang Rong;Wang Wen(Department of Gastroenterology,900 Hospital of the Joint Logistics Team,Fuzong Clinical Medical College of Fujian Medical University,Eastern Hospital Affiliated to Xiamen University,Fuzhou 350025,China)
出处
《中华胃肠内镜电子杂志》
2019年第3期121-124,共4页
Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition)
基金
福建省社会发展引导性(重点)项目(2018Y0066)
关键词
结直肠癌
新辅助治疗
疗效评价
Colorectal cancer
Neoadjuvant therapy
Therapeutic evaluation
